机译:使用老年肺癌患者的老年患者患者评估脆弱性和化疗风险的前瞻性临床试验
Division of Medical Oncology and Respiratory Medicine Department of Internal Medicine Faculty of;
Division of Medical Oncology and Respiratory Medicine Department of Internal Medicine Faculty of;
Division of Medical Oncology and Respiratory Medicine Department of Internal Medicine Faculty of;
Division of Medical Oncology and Respiratory Medicine Department of Internal Medicine Faculty of;
Division of Medical Oncology and Respiratory Medicine Department of Internal Medicine Faculty of;
Division of Medical Oncology and Respiratory Medicine Department of Internal Medicine Faculty of;
Division of Medical Oncology and Respiratory Medicine Department of Internal Medicine Faculty of;
Division of Medical Oncology and Respiratory Medicine Department of Internal Medicine Faculty of;
Division of Medical Oncology and Respiratory Medicine Department of Internal Medicine Faculty of;
Division of Medical Oncology and Respiratory Medicine Department of Internal Medicine Faculty of;
Division of Medical Oncology and Respiratory Medicine Department of Internal Medicine Faculty of;
Division of Medical ServiceShimane University HospitalIzumo Japan;
Toshiba Medical Systems CorporationTochigi Japan;
Department of Medical Informatics Faculty of MedicineShimane UniversityIzumo Japan;
Department of Medical Informatics Faculty of MedicineShimane UniversityIzumo Japan;
Division of Medical Oncology and Respiratory Medicine Department of Internal Medicine Faculty of;
chemotherapy; EGFR mutation; geriatric assessment; geriatric oncology; lung cancer;
机译:使用老年肺癌患者的老年患者患者评估脆弱性和化疗风险的前瞻性临床试验
机译:小细胞肺癌患者对一线化疗反应后接受marimastat的前瞻性,随机,双盲,安慰剂对照试验:加拿大国家癌症研究所临床试验组和欧洲试验
机译:吉西他滨联合厄洛替尼的多中心II期随机试验在进展中而非相反,用于通过综合老年病评估选择的晚期非小细胞肺癌弱势老年患者(GFPC 0505研究)
机译:细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
机译:癌症患者65岁及以上经受I期临床试验的营养风险
机译:韩国癌症研究小组老年分数(KG)-7(一种新型的老年筛查工具)在接受一线姑息化疗的晚期癌症晚期患者中的前瞻性验证
机译:在老年肺癌患者中使用老年患者的老年患者评估脆弱性和化疗风险的前瞻性临床试验